Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8689860 | Neuromuscular Disorders | 2018 | 8 Pages |
Abstract
The development of new therapeutic agents for the treatment of Duchenne muscular dystrophy has put a focus on defining outcome measures most sensitive to capture treatment effects. This cross-sectional analysis investigates the relation between validated clinical assessments such as the 6-minute walk test, motor function measure and quantitative muscle MRI of thigh muscles in ambulant Duchenne muscular dystrophy patients, aged 6.5 to 10.8 years (mean 8.2, SD 1.1). Quantitative muscle MRI included the mean fat fraction using a 2-point Dixon technique, and transverse relaxation time (T2) measurements. All clinical assessments were highly significantly inter-correlated with pâ<â0.001. The strongest correlation with the motor function measure and its D1-subscore was shown by the 6-minute walk test. Clinical assessments showed no correlation with age. Importantly, quantitative muscle MRI values significantly correlated with all clinical assessments with the extensors showing the strongest correlation. In contrast to the clinical assessments, quantitative muscle MRI values were highly significantly correlated with age. In conclusion, the motor function measure and timed function tests measure disease severity in a highly comparable fashion and all tests correlated with quantitative muscle MRI values quantifying fatty muscle degeneration.
Keywords
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Simone Schmidt, Patricia Hafner, Andrea Klein, Daniela Rubino-Nacht, Vanya Gocheva, Jonas Schroeder, Arjith Naduvilekoot Devasia, Stephanie Zuesli, Guenther Bernert, Vincent Laugel, Clemens Bloetzer, Maja Steinlin, Andrea Capone, Monika Gloor,